[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334320-105":59,"doc-detail-334320-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comparative-analysis-of-cancer-statistics-in-china-and-the-united-states-in-2024-research-report","Comparative analysis of cancer statistics in China and the United States in 2024 - Research report","","Cancer patterns in China are increasingly similar to those in the United States, prompting a comparative assessment of recent cancer profiles, trends, and determinants across both countries. Using open-source datasets, the study calculates 2024 cancer cases and deaths by combining GLOBOCAN 2022 estimates with United Nations population estimates. Incidence and mortality trends are drawn from SEER and US National Center for Health Statistics, and from China’s National Cancer Center cancer registries. A decomposition approach based on GBD quantifies contributions of four determinants. Results estimate 3,246,625 and 2,510,597 new cases and 1,699,066 and 640,038 deaths in China versus the US, with divergent incidence patterns by cancer type. Cancer deaths are largely driven by adult population growth and aging, while case fatality rates contribute to decreases in both countries. Conclusions highlight progress in China alongside a need to strengthen prevention and control by adopting US strategies to address aging and curb rising trends.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comparative-analysis-of-cancer-statistics-in-china-and-the-united-states-in-2024-research-report/334320/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comparative-analysis-of-cancer-statistics-in-china-and-the-united-states-in-2024-research-report/334320.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were 2024 cancer cases and deaths estimated for China and the US?","Question",{"text":112,"@type":113},"The study used GLOBOCAN 2022 cancer estimates together with United Nations population estimates to calculate 2024 cases and deaths for both countries.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which data sources were used for incidence and mortality trends?",{"text":117,"@type":113},"Incidence and mortality trends came from SEER and the US National Center for Health Statistics in the US, and from cancer registry reports from China’s National Cancer Center (NCC).",{"name":119,"@type":110,"acceptedAnswer":120},"What factors were identified as main contributors to changes in cancer deaths?",{"text":121,"@type":113},"Increases in adult population size and population aging were main reasons for higher cancer deaths. Case fatality rates were a main reason for decreases in cancer deaths in both countries.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334320,1790218895,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":4},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Comparative analysis of cancer statistics in China and the United States in 2024  \nYujie Wu, Siyi He, Mengdi Cao, Yi Teng, Qianru Li, Nuopei Tan, Jiachen Wang, Tingting Zuo, Tianyi Li, Yuanjie Zheng, Changfa Xia, Wanqing Chen  \nOffice of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.  \nAbstract  \nBackground: Cancer patterns in China are becoming similar to those in the United States (US) . Comparing the recent cancer profiles, trends, and determinants in China and the US can provide useful reference data.  \nMethods: This study used open-source data. We used GLOBOCAN 2022 cancer estimates and United Nations population estimates to calculate cancer cases and deaths in both countries during 2024. Data on cancer incidence and mortality trends were obtained from the Surveillance, Epidemiology, and End Results (SEER) program and National Centre for Health Statistics in the US and cancer registry reports of the National Cancer Center (NCC) of China. Data from the Global Burden of Disease study (GBD) and a decomposition approach were used to estimate the contributions of four determinants to the change in cancer deaths. Results: In 2024, there are an estimated 3,246,625 and 2,510,597 new cancer cases and 1,699,066 and 640,038 cancer deaths in China and the US, respectively. The highest estimated cancer cases are lung cancer in China and breast cancer in the US. The age-standardized incidence rates of lung and colorectal cancer in the US, and stomach, liver, and esophageal cancer in China have decreased, but the incidence rates of liver cancer in the US and colorectal cancer, prostate cancer in men, and cervical cancer in women in China have increased. Increases in the adult population size and population aging are main reasons for the increase in cancer deaths; case fatality rates are a main reason for the decrease in cancer deaths in both countries.  \nConclusions: China has made progress in cancer control but lags the US. Considering the transformation in China’s pattern of cancers epidemiology, it is imperative to develop stronger policies by adopting the cancer prevention and control strategies used in the US to address population aging and curb growing cancer trends.  \nKeywords: Cancer; Incidence; Mortality; Aging; China; United States; Lung cancer; Breast cancer; Esophageal cancer; Stomach cancer; Liver cancer  \nIntroduction  \nCancer has become one of the leading causes of human death owing to its chronic progression and serious mortality rates. [1] Cancer is associated with substantial societal and macroeconomic costs that vary in degree according to cancer type, geographic region, and sex. [2] In the United States (US), the field of cancer control is ata crossroads. Although the US has made progress in the fight against cancer, that progress has not benefited all populations equitably. In relevant studies, socioeconomic disparities in cancer mortality have widened, especially for the most easily preventable and early detectable cancers (e.g., cervical cancer) . [3] Disadvantaged groups bear a disproportionate share of the cancer burden, a situation that is also present in China. Over the past few decades, China has experienced rapid economic and demographic  \n\n| Access this article online |  |\n| --- | --- |\n| Quick Response Code: | Website:\u003Cbr>[www.cmj.org](www.cmj.org) |\n|  | DOI:\u003Cbr>10.1097/CM9.0000000000003442 |\n\nchanges that have been accompanied by shifts in cancer epidemiology.  \nAccording to GLOBOCAN 2022 estimates, the total number of cancer cases in China and the US was 4,824,703 and 2,380,189, accounting for 24.2% and 11.9% of global cancer cases, respectively. [4] With increasing population size and population aging, the cancer burden in China is showing a gradual upward trend, and the cancer pattern is transitioning from that of a developing country to that of a develop","cbCaioXnUnE4obSi","https://ap.wps.com/l/cbCaioXnUnE4obSi","pdf",2199844,"English","# Introduction\n## Cancer burden and disparities\n# Methods\n## Data sources and estimation approach\n## Trend extraction and determinants decomposition\n# Results\n## Estimated cases and deaths in 2024\n## Incidence and mortality trend differences\n# Conclusions","[{\"question\":\"How were 2024 cancer cases and deaths estimated for China and the US?\",\"answer\":\"The study used GLOBOCAN 2022 cancer estimates together with United Nations population estimates to calculate 2024 cases and deaths for both countries.\"},{\"question\":\"Which data sources were used for incidence and mortality trends?\",\"answer\":\"Incidence and mortality trends came from SEER and the US National Center for Health Statistics in the US, and from cancer registry reports from China’s National Cancer Center (NCC).\"},{\"question\":\"What factors were identified as main contributors to changes in cancer deaths?\",\"answer\":\"Increases in adult population size and population aging were main reasons for higher cancer deaths. Case fatality rates were a main reason for decreases in cancer deaths in both countries.\"}]","Comparative analysis of cancer statistics in China and the United States in 2024 - Research report | PDF",1790006256]